semaglutide after breast cancer New research suggests GLP 1 medications like and tirzepatide, widely used for weight loss and diabetes, may also lower the risk of several obesity related cancers, including colorectal, endometrial, and SABCS 2025: Can GLP-1s Help

Do B-12 Injections Hurt

EJ has received research funding (paid to the institution they are affiliated with) from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Faes Farma, MSD, Novartis and Novo Nordisk, and has received advisory/consulting fees and/or other support from Amgen, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, MSD, Novo Nordisk, Technofarma, UCB and Viatris

Oxidative stress: An essential factor in the pathogenesis of gastrointestinal mucosal diseases

One in five Americans report ever taking a GLP-1 for weight loss or a chronic condition, according to a 2025 poll

This blog post aims to unpack that question, delving into the nuances of both forms of semaglutide and how they can support our weight loss journeys